Exchange: NASDAQ·Updated 07:01 PM EST
ORMP logo

ORMP Oramed Pharmaceuticals, Inc

$3.89
$0.19
(5.12%)
Today
Closed $3.90
$0.01
(0.26%)
After Hours
EarningsMar 25
Mkt Cap$161.33M
Vol346,576.00

About ORMP

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
61

Bullish Sentiment

How do you feel about ORMP?

Advertisement|Remove ads.